FONT-SIZE Plus   Neg

Mylan, Pfizer Announce Epinephrine Auto-injector Settlement Agreement With Teva

Mylan Inc. (MYL) said Meridian Medical Technologies, a Pfizer (PFE) subsidiary, has entered into a settlement agreement with Teva (TEVA) that will resolve pending patent litigation related to its abbreviated new drug application for a generic epinephrine auto-injector.

According to the settlement terms, Teva may launch a generic epinephrine auto-injector covered by its ANDA on June 22, 2015 or earlier under certain circumstances, subject to receipt of approval from the U.S. Food and Drug Administration. Teva currently does not have tentative approval from the FDA for its epinephrine auto-injector product.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Customers of Time Warner Cable in Midwest experienced outages that lasted around two hours on Monday evening, as Americans were busy making their last minute online purchases on Cyber Monday. In a very quiet move that would have gone unnoticed but for a scrutiny into the LinkedIn profile, Google has lapped up Robert Rose, former autopilot software engineering manager of Tesla, as part of the company's Google Robotics unit. International Business Machines Corp. (IBM) Monday predicted that Cyber Monday online sales would grow by more than 18 percent compared to 2014. Driven by a surge in mobile shopping, consumers indicate that Samsung, Sony and LG TVs as well as Apple Watch and Beats by Dre are at the top of their shopping...
comments powered by Disqus
Trade PFE now with 
Follow RTT